simendan has been researched along with Postoperative Complications in 83 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 17 (20.48) | 29.6817 |
| 2010's | 54 (65.06) | 24.3611 |
| 2020's | 12 (14.46) | 2.80 |
| Authors | Studies |
|---|---|
| Li, H; Lv, X; Niu, Z; Qiao, H; Sheng, W; Wang, T; Wu, J; Zhang, W | 1 |
| Chen, ZJ; Cheng, YQ; Li, ZS; Liu, C; Pan, T; Sun, YH; Wang, DJ; Wang, K; Zhang, H; Zhang, HT | 1 |
| Alexander, JH; Caruba, T; Charles-Nelson, A; Chatellier, G; Cholley, B; Heringlake, M; Mehta, RH; Sabatier, B; Toller, W; Yavchitz, A | 1 |
| Alexander, JH; Argenziano, M; de Varennes, B; Duncan, AI; Fremes, S; Goodman, SG; Kochar, A; Lopes, RD; Mazer, DC; Mehta, RH; van Diepen, S; Westerhout, CM; Whitlock, R; Zheng, Y | 1 |
| Mielke, JAR; Ramakrishna, H; Welker, CC | 1 |
| Barrera Serrano, R; Bellido Estevez, I; Cruz Mañas, J; Escalona Belmonte, JJ; Gomez Luque, A; Guerrero Orriach, JL; Hernandez Rodriguez, P; Malo Manso, A; Navarro Arce, I; Raigón Ponferrada, A; Ramirez Aliaga, M; Ramirez Fernandez, A; Rubio Navarro, M; Toledo Medina, CS | 1 |
| Cui, C; Fan, Y; Tan, Q; Wang, A; Wang, F; Wang, G; Wang, J; Zhang, J; Zi, J | 1 |
| Allam, M; Dawou, O; Eldegwy, M; Elshihy, E; Omar, A; Rouchdy, A; Soliman, SAH | 1 |
| Abubakirov, MN; Belletti, A; Bianchi, A; Brazzi, L; Calabrò, MG; Crivellari, M; Di Tomasso, N; Fominskiy, EV; Garofalo, E; Grigoryev, EV; Guarracino, F; Landoni, G; Lembo, R; Likhvantsev, VV; Lomivorotov, VV; Monaco, F; Oriani, A; Pasyuga, VV; Paternoster, G; Pisano, A; Scandroglio, AM; Yavorovskiy, A; Zangrillo, A | 1 |
| Álvarez-Castillo, A; Ferrer-Rodríguez, J; García-González, MJ; Iribarren-Sarrías, JL; Jiménez-Rivera, JJ; Jorge-Pérez, P; Lacalzada-Almeida, J; Martínez-Sanz, R; Montoto-López, J; Pérez-Hernández, R | 1 |
| Akchurin, RS; Dzybinskaya, EV; Gazizova, VP; Gramovich, VV; Shiryaev, AA; Stukalova, OV; Vlasova, EE | 1 |
| Dashkevich, A; Juchem, G; Kilger, E; Mehringer, L; Schünemann, M; Weis, M; Woehrle, T | 1 |
| Alexander, JH; Alhanti, B; Fremes, S; Goodman, SG; Heringlake, M; Jawitz, OK; Lopes, RD; Mehta, RH; Meyer, SR; Raman, V; Stafford-Smith, M; Stebbins, AS; van Diepen, S; Whitlock, R | 1 |
| Alexander, JH; Anstrom, KJ; Argenziano, M; Bozinovski, J; Duncan, A; Fremes, S; Goodman, SG; Harrington, RA; Harrison, RW; Hay, D; Heringlake, M; Jankowich, R; Kalavrouziotis, D; Leimberger, JD; Levy, JH; Luber, J; Marcel, R; Mehta, RH; Meza, J; Murphy, E; Nagpal, D; Park, S; Soltesz, EG; Toller, W; van Diepen, S; Wang, A | 1 |
| Abubakirov, MN; Alvaro, G; Amantea, B; Baiocchi, M; Belletti, A; Bellomo, R; Bertini, P; Bianchi, A; Boboshko, VA; Bove, T; Brazzi, L; Calabrò, MG; Grigoryev, EV; Guarracino, F; Landoni, G; Lembo, R; Likhvantsev, VV; Lobreglio, R; Lomivorotov, VV; Michienzi, MG; Monaco, F; Pappalardo, F; Pasyuga, VV; Pisano, A; Salgado-Filho, MF; Scandroglio, AM; Shukevich, DL; Verniero, L; Zabelina, TS; Zangrillo, A | 1 |
| Hummel, J; Rücker, G; Stiller, B | 2 |
| Aït Hamou, N; Amour, J; Boughenou, MF; Boyer, J; Carillion, A; Caruba, T; Charles-Nelson, A; Chatellier, G; Cholley, B; Desebbe, O; Durand, M; Fellahi, JL; Girard, C; Grosjean, S; Guidon, C; Guinet, P; Lévy, F; Menasché, P; Miguet, B; Ouattara, A; Pirracchio, R; Radutoiu, M; Robin, E; Rosier, S; Rozec, B; Squara, P; Villacorta, J | 1 |
| Belletti, A; Cassina, T; Clivio, S; Putzu, A | 1 |
| Cruz-Manas, J; Escalona-Belmonte, JJ; Guerrero Orriach, JL; Ramirez-Fernandez, A; Rubio-Navarro, M | 1 |
| Gao, X; Hu, C; Liu, P; Sun, L; Wang, Y; Xu, Z; Zhang, Y; Zhou, X | 1 |
| Incalzi, RA; Massini, C; Migale, M; Santillo, E | 1 |
| Alvaro, G; Belletti, A; Boboshko, VA; Bove, T; Brazzi, L; Calabrò, MG; Comis, M; Frassoni, S; Grigoryev, EV; Guarracino, F; Lembo, R; Likhvantsev, VV; Lomivorotov, VV; Monaco, F; Navalesi, P; Pasyuga, VV; Paternoster, G; Pisano, A; Scandroglio, AM; Zangrillo, A | 1 |
| Conte, SM; Davies, RA; De Bono, JA; Florisson, DS; Newcomb, AE | 1 |
| González, JM; González, L; Juarez, P; Portela, F; Sadaba, R; Santana, L; Tena, MÁ; Urso, S | 1 |
| Chen, P; Li, Z; Tian, X; Wang, J; Wang, Z; Wu, X; Yan, T | 1 |
| Cheng, B; Gong, Y; He, X; Wang, B | 1 |
| Chan, XL; Ng, KT; Tan, W; Wang, CY | 1 |
| Chen, L; He, Y; Qing, X; Zhang, Y; Zhu, J | 1 |
| Beiras-Fernandez, A; Kornberger, A; Kur, F; Oberhoffer, M; Vahl, CF; Weis, F; Weis, M | 1 |
| Liao, X; Liu, B; Wang, W; Yu, H; Zhou, X | 1 |
| Alexander, JH; Anstrom, KJ; Argenziano, M; Cowper, PA; Duncan, AE; Fremes, S; Goodman, SG; Heringlake, M; Jankowich, R; Knight, JD; Leimberger, JD; Levy, JH; Lopes, RD; Luber, J; Mark, DB; Mehta, RH; Nagpal, AD; Teoh, K; Toller, W; van Diepen, S | 1 |
| Alexander, JH; Harrington, RA; Harrison, RW; Hasselblad, V; Levin, R; Mehta, RH | 1 |
| Alvarez, J; Baluja, A; Caruezo, V; Castroagudin, J; Otero, P; Rial, M; Rodriguez, A; Rodriguez, I; Rodriguez, J; Selas, S; Taboada, M; Tome, S; Veiras, S | 1 |
| Gooi, A; Karl, T; Pandey, R; Ramakrishnan, K | 1 |
| Aleixandre, L; Cortell, J; Herrera, P; Loro, JM; Valera, F; Vicente, R | 1 |
| Abacilar, AF; Dogan, OF | 1 |
| Baysal, A; Dogukan, M; Gundogus, N; Kocak, T; Koksal, C; Yanartas, M | 1 |
| Cruz, J; Escalona, JJ; Florez, A; Galan, M; Iglesias, P; Melero, JM; Orriach Guerrero, JL; Ramirez Fernandez, A; Ramirez, M; Rodriguez, MJ; Rubio, M | 1 |
| Cruz Mañas, J; Galán Ortega, M; Guerrero Orriach, JL; Iglesias, P; Navarro Arce, I; Rubio Navarro, M | 1 |
| Bishnoi, A; Gandhi, H; Gandhi, S; Garg, P; Malhotra, A; Sharma, P | 1 |
| Rabanal, JM; Real, MI; Williams, M | 1 |
| Balzer, F; Braun, JP; Grubitzsch, H; Kastrup, M; Sander, M; Spies, C; Treskatsch, S; Wernecke, KD | 1 |
| Burkhardt, BE; Rücker, G; Stiller, B | 1 |
| Balzer, F; Braun, JP; Erb, JM; Geyer, T; Grubitzsch, H; Kastrup, M; Sander, M; Spies, CD; Treskatsch, S; Wernecke, KD | 1 |
| Hote, M; Kiran, U; Malik, V; Subramanian, A | 1 |
| Altarabsheh, SE; Avery, EG; Cho, YH; Deo, SV; Hang, D; Lim, JY; Markowitz, AH; McGraw, M; Park, SJ; Rababa'h, A | 1 |
| Freeman, LJ; Rafiq, I | 1 |
| Chen, D; Gong, J; Liu, B; Liu, M; Wang, W; Zhou, C | 1 |
| Ariza Villanueva, D; Cruz Mañas, J; Florez Vela, A; Galán Ortega, M; Guerrero Orriach, JL; Moreno Cortés, I; Ramírez Fernandez, A; Rubio Navarro, M | 1 |
| Landoni, G; Monti, G; Pisano, A | 1 |
| Alvaro, G; Amantea, B; Auci, E; Auriemma, S; Baiocchi, M; Bianchi, A; Biondi-Zoccai, G; Bove, T; Bradic, N; Buscaglia, G; Calabrò, MG; Cariello, C; Corcione, A; De Vuono, G; Fominskiy, E; Frontini, M; Galdieri, N; Gemma, M; Gianni, S; Grigoryev, E; Guarracino, F; Landoni, G; Lembo, R; Likhvantsev, V; Lipinski, MJ; Lobreglio, R; Lomivorotov, VV; Monaco, F; Pala, G; Paternoster, G; Pisano, A; Sangalli, F; Wang, CY; Zangrillo, A; Zucchetti, MC | 1 |
| Binder, C; Distelmaier, K; Goliasch, G; Heinz, G; Hülsmann, M; Koinig, H; Lang, IM; Maurer, G; Niessner, A; Roth, C; Schrutka, L; Speidl, W; Steinlechner, B | 1 |
| Mauriat, P; Séguéla, PE; Tafer, N; Thambo, JB | 1 |
| Anastasiadis, K; Antonitsis, P; Argiriadou, H; Asteriou, C; Grosomanidis, V; Kleontas, A; Tossios, P; Vranis, K | 1 |
| Fu, S; Li, S; Xiao, Y; Xu, G | 1 |
| Altinsoy, HB; Atalay, A; Atalay, H; Azboy, D; Colak, S; Dogan, OF; Temizturk, Z | 1 |
| Arnold, A; Böning, A; Görlach, G; Grieshaber, P; Lipp, S; Niemann, B; Roth, P; Wilhelm, J; Wollbrück, M | 1 |
| Alexander, JH; Anstrom, KJ; Bokesch, P; Fremes, S; Goodman, SG; Harrington, RA; Harrison, RW; Hay, D; Heringlake, M; Jankowich, R; Leimberger, JD; Levy, JH; Luber, J; Mehta, RH; Meza, J; Parrotta, J; Swartz, M; Toller, W; Tourt-Uhlig, S; Van Diepen, S | 1 |
| Lin, L; Sherrah, A; Simmons, L; Vallely, M | 1 |
| Ertmer, C; Morelli, A; Westphal, M | 1 |
| Kapralou, A; Katsaragakis, S; Markogiannakis, H; Theodorou, D; Toufektzian, L | 1 |
| Boethig, D; Goerler, H; Huber, D; Osthaus, WA; Sasse, M; Sümpelmann, R; Winterhalter, M | 1 |
| Beiras-Fernandez, A; Hauer, D; Kur, F; Schmoeckel, M; Weis, FC; Weis, M | 1 |
| Li, G; Liu, T; Xu, G | 1 |
| Eriksson, HI; Heikkinen, LO; Jalonen, JR; Kivikko, M; Kuitunen, AH; Kuttila, KT; Laine, M; Leino, KA; Peräkylä, TK; Salmenperä, MT; Sarapohja, T; Suojaranta-Ylinen, RT; Valtonen, M | 1 |
| Beiras-Fernandez, A; Kaczmarek, I; Kur, F; Reichart, B; Schmoeckel, M; Sodian, R; Weis, F; Weis, M | 1 |
| Bignami, E; Biondi-Zoccai, G; Bruno, G; Corno, L; Gerli, C; Landoni, G; Mizzi, A; Zambon, M; Zangrillo, A | 1 |
| Goldstein, DJ; Stern, DR; Sylvin, EA | 1 |
| Eija, R; Fredrik, Y; Hannu, T; Jensen, H; Jussi, M; Kai, K; Kirsi, A; Matti, P; Tatu, J; Tuomas, M; Vesa, A | 1 |
| Hernández, A; Miranda, A; Parada, A | 1 |
| Cogo, PE; Di Chiara, L; Favia, I; Garisto, C; Ricci, Z; Vitale, V | 1 |
| Arocas-Casañ, V; Blázquez-Álvarez, MJ; Cárceles-Barón, MD; de la Rubia-Nieto, A; Fernández de Palencia-Espinosa, MA | 1 |
| Ewert, P; Hetzer, R; Lange, PE; Luther, YC; Mühler, EG; Nasseri, B; Redlin, M; Schulze-Neick, I; Stiller, B | 1 |
| Braun, JP; Kastrup, M; Liu, J; Schneider, M | 1 |
| Plöchl, W; Rajek, A | 1 |
| Brussel, T; Ellger, BM; Schmidt, C; Van Aken, HK; Zahn, PK | 1 |
| Braun, JP; Doepfmer, UR; Dohmen, PM; Jasulaitis, D; Kastrup, M; Konertz, W; Moshirzadeh, M; Spies, C; von Heymann, C | 1 |
| Morais, RJ | 1 |
| Lechner, E; Mair, R; Moosbauer, W; Pinter, M; Tulzer, G | 1 |
| Archan, S; Toller, W | 1 |
| Kapralou, A; Katsaragakis, S; Kofinas, G; Larentzakis, A; Markogiannakis, H; Menenakos, E; Theodoraki, EM; Theodorou, D | 1 |
| Blanco, N; Botbol, AL; Degrange, MA; del Mazo, CD; Levin, RL; Porcile, R; Salvagio, F; Tanus, E | 1 |
28 review(s) available for simendan and Postoperative Complications
| Article | Year |
|---|---|
Prophylactic levosimendan in patients with low ejection fraction undergoing coronary artery bypass grafting: A pooled analysis of two multicentre randomised controlled trials.
Topics: Coronary Artery Bypass; Humans; Multicenter Studies as Topic; Postoperative Complications; Randomized Controlled Trials as Topic; Simendan; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Function, Left | 2022 |
Levosimendan and Low Cardiac Output After Cardiac Surgery: Analysis of Trial Data.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Humans; Hydrazones; Postoperative Complications; Simendan | 2023 |
Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.
Topics: Assisted Circulation; Cardiac Output, Low; Cardiotonic Agents; Child, Preschool; Heart Defects, Congenital; Humans; Hydrazones; Infant; Intensive Care Units, Pediatric; Length of Stay; Postoperative Complications; Pyridazines; Randomized Controlled Trials as Topic; Respiration, Artificial; Simendan; Syndrome | 2017 |
Perioperative levosimendan in cardiac surgery: A systematic review with meta-analysis and trial sequential analysis.
Topics: Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Humans; Hydrazones; Perioperative Care; Postoperative Complications; Pyridazines; Randomized Controlled Trials as Topic; Simendan | 2018 |
Calcium Sensitizers in Cardiac Surgery: Who, When, How and Why?
Topics: Animals; Cardiac Surgical Procedures; Cardiotonic Agents; Clinical Decision-Making; Drug Administration Schedule; Humans; Patient Selection; Perioperative Care; Postoperative Complications; Risk Factors; Simendan; Treatment Outcome; Vasodilator Agents | 2018 |
Effect of levosimendan on clinical outcomes in adult patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials.
Topics: Adult; Cardiac Surgical Procedures; Global Health; Heart Diseases; Humans; Incidence; Length of Stay; Phosphodiesterase 3 Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Simendan; Survival Rate | 2018 |
Levosimendan for Perioperative Cardioprotection: Myth or Reality?
Topics: Cardiac Output, Low; Cardiotonic Agents; Humans; Hydrazones; Postoperative Complications; Pyridazines; Retrospective Studies; Simendan | 2018 |
Levosimendan Following Cardiac Surgery.
Topics: Adult; Cardiac Surgical Procedures; Cardiotonic Agents; Female; Humans; Male; Postoperative Care; Postoperative Complications; Simendan | 2019 |
Levosimendan versus placebo in cardiac surgery: a systematic review and meta-analysis.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Humans; Postoperative Complications; Simendan | 2018 |
Effects of levosimendan on mortality in patients undergoing cardiac surgery: A systematic review and meta-analysis.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Databases, Bibliographic; Humans; Hydrazones; Phosphodiesterase Inhibitors; Postoperative Complications; Pyridazines; Randomized Controlled Trials as Topic; Simendan | 2018 |
Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery: An Update Meta-Analysis and Trial Sequential Analysis.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Humans; Hydrazones; Postoperative Complications; Pyridazines; Randomized Controlled Trials as Topic; Renal Replacement Therapy; Simendan; Ventricular Dysfunction, Left | 2018 |
Levosimendan use in patients with preoperative low ejection fraction undergoing cardiac surgery: A systematic review with meta-analysis and trial sequential analysis.
Topics: Cardiac Surgical Procedures; Cardiotonic Agents; Humans; Postoperative Complications; Preoperative Care; Simendan; Stroke Volume; Ventricular Dysfunction, Left | 2019 |
Levosimendan in patients with low cardiac output syndrome undergoing cardiac surgery: A systematic review and meta-analysis.
Topics: Acute Kidney Injury; Cardiac Output; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Humans; Myocardial Infarction; Odds Ratio; Placebos; Postoperative Complications; Randomized Controlled Trials as Topic; Simendan; Time Factors | 2019 |
The efficacy and safety of prophylactic use of levosimendan on patients undergoing coronary artery bypass graft: a systematic review and meta-analysis.
Topics: Atrial Fibrillation; Coronary Artery Bypass; Humans; Postoperative Complications; Randomized Controlled Trials as Topic; Simendan; Treatment Outcome | 2019 |
Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis.
Topics: Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiotonic Agents; Data Interpretation, Statistical; Hospital Mortality; Humans; Hydrazones; Perioperative Care; Postoperative Complications; Publication Bias; Pyridazines; Randomized Controlled Trials as Topic; Regression Analysis; Risk Assessment; Simendan; Stroke Volume; Survival; Ventricular Dysfunction, Left | 2013 |
Preoperative levosimendan. A new way for organoprotection.
Topics: Animals; Cardiac Surgical Procedures; Humans; Hydrazones; Postoperative Complications; Preoperative Care; Pyridazines; Simendan; Vasodilator Agents; Ventricular Dysfunction, Left | 2014 |
Perioperative management of pulmonary hypertension during lung transplantation (a lesson for other anaesthesia settings).
Topics: Anesthesia, General; Cardiotonic Agents; Constriction; Disease Management; Drug Therapy, Combination; Eicosanoids; Extracorporeal Membrane Oxygenation; Heart Atria; Hemodynamics; Humans; Hydrazones; Hypertension, Pulmonary; Intraoperative Complications; Lung Transplantation; Monitoring, Intraoperative; Nitric Oxide Donors; One-Lung Ventilation; Operative Time; Phosphodiesterase Inhibitors; Postoperative Complications; Preanesthetic Medication; Pulmonary Artery; Pyridazines; Respiration, Artificial; Simendan; Vasodilator Agents | 2014 |
Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease.
Topics: Cardiac Output, Low; Cardiotonic Agents; Dobutamine; Heart Defects, Congenital; Humans; Hydrazones; Infant; Infant, Newborn; Milrinone; Postoperative Complications; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Syndrome; Time Factors | 2015 |
Levosimendan Reduces Mortality in Adults with Left Ventricular Dysfunction Undergoing Cardiac Surgery: A Systematic Review and Meta-analysis.
Topics: Acute Kidney Injury; Adult; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Databases, Bibliographic; Humans; Hydrazones; Postoperative Complications; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Ventricular Dysfunction, Left | 2015 |
Levosimendan for Prevention of Acute Kidney Injury After Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials.
Topics: Acute Kidney Injury; Adult; Cardiac Surgical Procedures; Humans; Hydrazones; Kidney; Outcome Assessment, Health Care; Postoperative Complications; Protective Agents; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Vasodilator Agents | 2016 |
Levosimendan: new indications and evidence for reduction in perioperative mortality?
Topics: Acute Kidney Injury; Cardiac Output; Cardiac Surgical Procedures; Cardiotonic Agents; Critical Care; Humans; Hydrazones; Perioperative Care; Perioperative Period; Postoperative Complications; Pyridazines; Simendan | 2016 |
[Use of levosimendan in children].
Topics: Cardiac Output, Low; Cardiotonic Agents; Child; Extracorporeal Circulation; Heart Failure; Humans; Hydrazones; Postoperative Complications; Pyridazines; Simendan | 2016 |
Recent Perioperative Pharmacological Prevention of Acute Kidney Injury after Cardiac Surgery: A Narrative Review.
Topics: Acute Kidney Injury; Cardiac Surgical Procedures; Dexmedetomidine; Humans; Hydrazones; Perioperative Care; Postoperative Complications; Pyridazines; Risk Factors; Simendan | 2017 |
Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.
Topics: Assisted Circulation; Cardiac Output, Low; Cardiotonic Agents; Coronary Care Units; Heart Defects, Congenital; Humans; Hydrazones; Length of Stay; Postoperative Complications; Pyridazines; Randomized Controlled Trials as Topic; Respiration, Artificial; Simendan | 2017 |
Reducing mortality in cardiac surgery with levosimendan: a meta-analysis of randomized controlled trials.
Topics: Cardiopulmonary Bypass; Cardiotonic Agents; Coronary Artery Bypass, Off-Pump; Heart Diseases; Humans; Hydrazones; Postoperative Complications; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Treatment Outcome | 2010 |
Mechanical support for postcardiotomy cardiogenic shock: has progress been made?
Topics: Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiotonic Agents; Equipment Design; Extracorporeal Membrane Oxygenation; Heart-Assist Devices; Humans; Hydrazones; New York; Postoperative Complications; Pyridazines; Shock, Cardiogenic; Simendan; Time Factors | 2010 |
[Levosimendan reduces mortality in cardiac surgery: a systematic review and meta-analysis].
Topics: Cardiac Surgical Procedures; Cardiotonic Agents; Humans; Hydrazones; Postoperative Complications; Pyridazines; Simendan; Vasodilator Agents | 2012 |
Levosimendan: current status and future prospects.
Topics: Acute Disease; Adrenergic beta-Antagonists; Cardiotonic Agents; Heart Failure; Humans; Hydrazones; Postoperative Complications; Pyridazines; Shock, Septic; Simendan; Ventricular Dysfunction, Right | 2008 |
22 trial(s) available for simendan and Postoperative Complications
| Article | Year |
|---|---|
Predictors and associated clinical outcomes of low cardiac output syndrome following cardiac surgery: insights from the LEVO-CTS trial.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Humans; Hydrazones; Postoperative Complications; Pyridazines; Simendan; Ventricular Dysfunction, Left | 2022 |
Preservation of renal function in cardiac surgery patients with low cardiac output syndrome: levosimendan vs beta agonists.
Topics: Adrenergic beta-Agonists; Aged; Aged, 80 and over; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Female; Humans; Incidence; Male; Middle Aged; Postoperative Complications; Renal Insufficiency; Simendan | 2019 |
Prophylactic use of levosimendan in pediatric patients undergoing cardiac surgery: a prospective randomized controlled trial.
Topics: Biomarkers; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiotonic Agents; Child, Preschool; Double-Blind Method; Female; Heart Defects, Congenital; Hemodynamics; Humans; Incidence; Infant; Kaplan-Meier Estimate; Length of Stay; Male; Postoperative Complications; Prospective Studies; Respiration, Artificial; Simendan; Treatment Outcome | 2019 |
Comparison of Levosimendan Versus IABP in Patients with Poor Left Ventricular Function Undergoing Coronary Artery Bypass Graft Surgery.
Topics: Cardiotonic Agents; Coronary Artery Bypass; Critical Care; Female; Hemodynamics; Humans; Infusions, Intravenous; Intra-Aortic Balloon Pumping; Length of Stay; Male; Middle Aged; Postoperative Complications; Prospective Studies; Risk Factors; Simendan; Ventricular Dysfunction, Left | 2020 |
Long-term outcome of perioperative low cardiac output syndrome in cardiac surgery: 1-year results of a multicenter randomized trial.
Topics: Age Factors; Cardiac Output, Low; Cardiotonic Agents; Cardiovascular Surgical Procedures; Double-Blind Method; Female; Humans; Male; Middle Aged; Postoperative Complications; Simendan; Survival Analysis; Treatment Outcome | 2020 |
Association between levosimendan, postoperative AKI, and mortality in cardiac surgery: Insights from the LEVO-CTS trial.
Topics: Acute Kidney Injury; Aged; Cardiac Surgical Procedures; Cardiotonic Agents; Coronary Artery Bypass; Female; Humans; Male; Middle Aged; Odds Ratio; Placebos; Postoperative Complications; Regression Analysis; Risk Factors; Simendan; Stroke Volume; Ventricular Dysfunction, Left | 2021 |
Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.
Topics: Aged; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Double-Blind Method; Female; Heart-Assist Devices; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Mortality; Myocardial Infarction; Perioperative Period; Postoperative Complications; Pyridazines; Renal Replacement Therapy; Simendan; Stroke Volume; Treatment Failure; Ventricular Dysfunction, Left | 2017 |
Levosimendan for Hemodynamic Support after Cardiac Surgery.
Topics: Aged; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Double-Blind Method; Female; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Mortality; Perioperative Period; Postoperative Complications; Pyridazines; Respiration, Artificial; Simendan; Stroke Volume; Treatment Failure | 2017 |
Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: The LICORN Randomized Clinical Trial.
Topics: Aged; Cardiac Output, Low; Cardiopulmonary Bypass; Cardiotonic Agents; Catecholamines; Coronary Artery Bypass; Double-Blind Method; Female; Heart-Assist Devices; Humans; Hydrazones; Infusions, Intravenous; Intention to Treat Analysis; Male; Middle Aged; Postoperative Complications; Premedication; Pyridazines; Renal Replacement Therapy; Simendan; Stroke Volume; Treatment Failure | 2017 |
Effect of Levosimendan on Renal Outcome in Cardiac Surgery Patients With Chronic Kidney Disease and Perioperative Cardiovascular Dysfunction: A Substudy of a Multicenter Randomized Trial.
Topics: Acute Kidney Injury; Aged; Brazil; Cardiac Surgical Procedures; Cardiotonic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Valve Diseases; Humans; Incidence; Italy; Male; Middle Aged; Mitral Valve; Perioperative Period; Postoperative Complications; Renal Insufficiency, Chronic; Russia; Simendan; Treatment Outcome | 2018 |
Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery.
Topics: Aged; Cardiotonic Agents; Coronary Artery Bypass; Coronary Artery Disease; Cost-Benefit Analysis; Double-Blind Method; Drug Costs; Female; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Hospital Costs; Humans; Male; Middle Aged; Postoperative Complications; Risk Assessment; Risk Factors; Simendan; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2020 |
A comparison of dobutamine and levosimendan on hepatic blood flow in patients with a low cardiac output state after cardiac surgery: a randomised controlled study.
Topics: Aged; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Dobutamine; Female; Hemodynamics; Humans; Hydrazones; Liver Circulation; Male; Postoperative Complications; Pyridazines; Simendan; Vascular Resistance | 2013 |
Levosimendan use decreases atrial fibrillation in patients after coronary artery bypass grafting: a pilot study.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Comorbidity; Coronary Artery Bypass; Double-Blind Method; Female; Humans; Hydrazones; Incidence; Male; Middle Aged; Pilot Projects; Placebo Effect; Postoperative Complications; Premedication; Pyridazines; Risk Assessment; Simendan; Treatment Outcome; Turkey | 2013 |
Levosimendan improves renal outcome in cardiac surgery: a randomized trial.
Topics: Adult; Aged; Cardiac Surgical Procedures; Creatinine; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Hydrazones; Kidney Diseases; Male; Middle Aged; Postoperative Complications; Prospective Studies; Pyridazines; Renal Replacement Therapy; Simendan; Stroke Volume; Treatment Outcome; Vasodilator Agents | 2014 |
Preoperative levosimendan in ischemic mitral valve repair.
Topics: Adult; Aged; Cardiopulmonary Bypass; Cardiotonic Agents; Coronary Artery Bypass; Coronary Artery Disease; Double-Blind Method; Female; Heart Valve Prosthesis Implantation; Hemodynamics; Humans; Hydrazones; India; Intensive Care Units; Length of Stay; Male; Middle Aged; Mitral Valve Annuloplasty; Mitral Valve Insufficiency; Postoperative Complications; Preoperative Care; Prospective Studies; Pyridazines; Respiration, Artificial; Simendan; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2014 |
Effect of Levosimendan on Diastolic Function in Patients Undergoing Coronary Artery Bypass Grafting: A Comparative Study.
Topics: Aged; Blood Pressure; Coronary Artery Bypass; Coronary Artery Disease; Diastole; Double-Blind Method; Female; Humans; Hydrazones; Male; Middle Aged; Postoperative Complications; Prospective Studies; Pyridazines; Simendan; Treatment Outcome; Vasodilator Agents | 2015 |
A randomized controlled trial of levosimendan to reduce mortality in high-risk cardiac surgery patients (CHEETAH): Rationale and design.
Topics: Acute Kidney Injury; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Double-Blind Method; Humans; Hydrazones; Infusions, Intravenous; Intensive Care Units; Intra-Aortic Balloon Pumping; Length of Stay; Postoperative Complications; Pyridazines; Respiration, Artificial; Simendan | 2016 |
Effectiveness of prophylactic levosimendan in patients with impaired left ventricular function undergoing coronary artery bypass grafting: a randomized pilot study.
Topics: Cardiac Output, Low; Cardiotonic Agents; Coronary Artery Bypass; Coronary Artery Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Finland; Follow-Up Studies; Humans; Hydrazones; Incidence; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Postoperative Complications; Prospective Studies; Pyridazines; Simendan; Stroke Volume; Survival Rate; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left; Ventricular Function, Left | 2016 |
Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requ
Topics: Administration, Intravenous; Adult; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiovascular Agents; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Hydrazones; Male; Middle Aged; Postoperative Complications; Pyridazines; Simendan; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left | 2016 |
Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function.
Topics: Aged; Analysis of Variance; Cardiopulmonary Bypass; Confidence Intervals; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Double-Blind Method; Education, Medical, Continuing; Female; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Monitoring, Intraoperative; Postoperative Complications; Preoperative Care; Prospective Studies; Pyridazines; Reference Values; Risk Assessment; Severity of Illness Index; Simendan; Stroke Volume; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left | 2009 |
Levosimendan infusion in newborns after corrective surgery for congenital heart disease: randomized controlled trial.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Heart Defects, Congenital; Humans; Hydrazones; Infant, Newborn; Infusions, Intravenous; Italy; Outcome Assessment, Health Care; Postoperative Complications; Pyridazines; Simendan | 2012 |
[The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome].
Topics: Cardiac Output, Low; Cardiotonic Agents; Dobutamine; Female; Humans; Hydrazones; Male; Middle Aged; Postoperative Complications; Prospective Studies; Pyridazines; Simendan | 2008 |
33 other study(ies) available for simendan and Postoperative Complications
| Article | Year |
|---|---|
Prospective Study on the Postoperative Use of Levosimendan After Conventional Heart Valve Replacement.
Topics: Aged; Cardiotonic Agents; Female; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Heart Valves; Humans; Length of Stay; Male; Postoperative Care; Postoperative Complications; Prospective Studies; Simendan | 2021 |
The evaluation of levosimendan in patients with acute myocardial infarction related ventricular septal rupture undergoing cardiac surgery: a prospective observational cohort study with propensity score analysis.
Topics: Acute Disease; Cardiac Surgical Procedures; Cardiotonic Agents; Female; Humans; Hydrazones; Male; Myocardial Infarction; Postoperative Complications; Propensity Score; Prospective Studies; Pyridazines; Simendan; Ventricular Septal Rupture | 2022 |
Preconditioning with levosimendan reduces postoperative low cardiac output in moderate-severe systolic dysfunction patients who will undergo elective coronary artery bypass graft surgery: a cost-effective strategy.
Topics: Aged; Cardiac Output, Low; Cardiotonic Agents; Coronary Artery Bypass; Coronary Artery Disease; Cost-Benefit Analysis; Elective Surgical Procedures; Female; Humans; Incidence; Male; Postoperative Complications; Simendan; Spain; Stroke Volume; Ventricular Function, Left | 2020 |
[The possibilities of using levosimendan in medical preparation to Coronary Artery Bypass Grafting in coronary artery disease patients with low left ventricular ejection fraction].
Topics: Coronary Artery Bypass; Coronary Artery Disease; Humans; Hydrazones; Postoperative Complications; Prospective Studies; Pyridazines; Retrospective Studies; Simendan; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2020 |
[Individualized use of levosimendan in cardiac surgery].
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Humans; Hydrazones; Postoperative Complications; Pyridazines; Retrospective Studies; Simendan; Stroke Volume; Ventricular Function, Left | 2021 |
Levosimendan as rescue therapy in low output syndrome after cardiac surgery: effects and predictors of outcome.
Topics: Aged; Cardiac Output; Cardiac Surgical Procedures; Cardiotonic Agents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Postoperative Complications; Prognosis; Retrospective Studies; Simendan; Survival Rate | 2019 |
Use of β-blockade and levosimendan for separation from extracorporeal life support in an infant with postoperative diastolic dysfunction.
Topics: Adrenergic beta-Antagonists; Aortic Valve Stenosis; Cardiotonic Agents; Diastole; Drug Therapy, Combination; Extracorporeal Circulation; Follow-Up Studies; Heart Valve Prosthesis Implantation; Humans; Hydrazones; Infant, Newborn; Male; Postoperative Complications; Pyridazines; Simendan; Ventricular Dysfunction; Ventricular Outflow Obstruction | 2013 |
[Nitrid oxide, levosimendan and sildenafile in a patient with right ventricle dysfunction and severe pulmonary hypertension after cardiac surgery].
Topics: Aged; Aorta; Dobutamine; Drug Synergism; Drug Therapy, Combination; Female; Heart Valve Prosthesis Implantation; Humans; Hydrazones; Hypertension, Pulmonary; Nitric Oxide; Norepinephrine; Postoperative Complications; Pyridazines; Sildenafil Citrate; Simendan; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Right | 2014 |
Preoperative levosimendan for right ventricular dysfunction before heart valve replacement surgery.
Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Echocardiography; Female; Follow-Up Studies; Heart Failure; Heart Valve Prosthesis Implantation; Humans; Hydrazones; Infusions, Intravenous; Male; Postoperative Complications; Preoperative Care; Pyridazines; Risk Assessment; Simendan; Spain; Treatment Outcome; Ventricular Dysfunction, Right | 2013 |
Early administration of levosimendan is associated with improved kidney function after cardiac surgery - a retrospective analysis.
Topics: Adult; Aged; Berlin; Coronary Artery Bypass; Female; Hospitals, University; Humans; Hydrazones; Intensive Care Units; Intraoperative Period; Kidney Diseases; Male; Postoperative Complications; Pyridazines; Retrospective Studies; Simendan; Vasodilator Agents | 2014 |
Early levosimendan administration is associated with decreased mortality after cardiac surgery.
Topics: Aged; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Coronary Artery Bypass; Female; Heart Valve Prosthesis Implantation; Hospital Mortality; Humans; Hydrazones; Intensive Care Units; Logistic Models; Male; Middle Aged; Odds Ratio; Postoperative Complications; Proportional Hazards Models; Pyridazines; Renal Insufficiency; Renal Replacement Therapy; Retrospective Studies; Simendan; Stroke Volume; Survival Rate; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left | 2015 |
Pulsed levosimendan therapy in the management of chronic end stage cardiac failure in 'adult congenital heart disease'.
Topics: Adult; Cardiac Surgical Procedures; Cardiotonic Agents; Disease Progression; Female; Heart Defects, Congenital; Heart Failure; Humans; Hydrazones; Life Expectancy; Male; Middle Aged; Postoperative Complications; Pyridazines; Quality of Life; Severity of Illness Index; Simendan; Treatment Outcome | 2015 |
Assessing the effect of preoperative levosimendan on renal function in patients with right ventricular dysfunction.
Topics: Acute Kidney Injury; Aged; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Female; Humans; Hydrazones; Kidney; Kidney Function Tests; Male; Middle Aged; Neuromuscular Blockade; Postoperative Complications; Preoperative Period; Pyridazines; Simendan; Ventricular Dysfunction, Right | 2017 |
Beneficial effects of levosimendan on survival in patients undergoing extracorporeal membrane oxygenation after cardiovascular surgery.
Topics: Aged; Anti-Arrhythmia Agents; Cardiovascular Surgical Procedures; Extracorporeal Membrane Oxygenation; Female; Follow-Up Studies; Humans; Hydrazones; Male; Middle Aged; Postoperative Complications; Pyridazines; Registries; Simendan; Survival Analysis; Treatment Outcome | 2016 |
Levosimendan Use Increases Cardiac Performance after Coronary Artery Bypass Grafting in End-Stage Renal Disease Patients.
Topics: Aged; Cardiac Output, Low; Coronary Artery Bypass; Female; Hemodynamics; Humans; Hydrazones; Kidney Failure, Chronic; Male; Middle Aged; Postoperative Complications; Preoperative Care; Pyridazines; Simendan; Vasodilator Agents | 2016 |
Impact of prophylactic administration of Levosimendan on short-term and long-term outcome in high-risk patients with severely reduced left-ventricular ejection fraction undergoing cardiac surgery - a retrospective analysis.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Cardiopulmonary Bypass; Cardiotonic Agents; Coronary Artery Bypass; Female; Humans; Hydrazones; Kidney; Male; Middle Aged; Postoperative Complications; Pyridazines; Retrospective Studies; Risk Factors; Simendan; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left | 2016 |
A case of mitral annuloplasty band dehiscence.
Topics: Aged; Defibrillators, Implantable; Echocardiography, Transesophageal; Follow-Up Studies; Heart Valve Prosthesis Implantation; Humans; Hydrazones; Male; Mitral Valve Annuloplasty; Mitral Valve Insufficiency; Postoperative Complications; Pyridazines; Reoperation; Risk Assessment; Severity of Illness Index; Simendan; Surgical Wound Dehiscence; Treatment Outcome | 2017 |
Levo is in the air: take a deep breath!
Topics: Administration, Inhalation; Adult; Animals; Cardiotonic Agents; Disease Models, Animal; Female; Hemodynamics; Humans; Hydrazones; Multiple Organ Failure; Postoperative Complications; Pyridazines; Rats; Respiratory Distress Syndrome; Risk Factors; Shock, Septic; Simendan | 2008 |
Perioperative cardiac evaluation: the importance of cardiac failure management.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Diuretics; Heart Failure; Humans; Hydrazones; Myocardial Ischemia; Postoperative Complications; Pyridazines; Simendan | 2008 |
First experiences with intraoperative Levosimendan in pediatric cardiac surgery.
Topics: Cardiac Output; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Heart; Heart Defects, Congenital; Hemodynamics; Humans; Hydrazones; Infant; Infant, Newborn; Infusions, Intravenous; Intraoperative Period; Lactic Acid; Length of Stay; Oxygen; Postoperative Complications; Pyridazines; Respiration, Artificial; Retrospective Studies; Simendan; Transposition of Great Vessels | 2009 |
The management of severe primary graft failure after cardiac transplantation.
Topics: Cardiomyopathy, Dilated; Cardiopulmonary Bypass; Extracorporeal Membrane Oxygenation; Graft Survival; Heart Transplantation; Hemodynamics; Humans; Hydrazones; Male; Middle Aged; Postoperative Complications; Pyridazines; Simendan; Treatment Failure; Vasodilator Agents | 2009 |
Levosimendan may prevent postoperative atrial fibrillation through anti-inflammatory and antioxidant modulation.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Atrial Fibrillation; Humans; Hydrazones; Postoperative Complications; Pyridazines; Simendan | 2009 |
Levosimendan: a new therapeutic option in the treatment of primary graft dysfunction after heart transplantation.
Topics: Adult; Aged; Cardiotonic Agents; Drug Therapy, Combination; Echocardiography; Echocardiography, Transesophageal; Female; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Hydrazones; Male; Middle Aged; Postoperative Complications; Pyridazines; Simendan; Ventricular Dysfunction, Left | 2009 |
Levosimendan decreases intracranial pressure after hypothermic circulatory arrest in a porcine model.
Topics: Animals; Animals, Newborn; Body Temperature; Brain; Circulatory Arrest, Deep Hypothermia Induced; Hemodynamics; Hydrazones; Infusions, Intravenous; Intracranial Pressure; Neuroprotective Agents; Oxygen Consumption; Postoperative Complications; Pyridazines; Simendan; Swine; Time Factors | 2011 |
[Retrospective descriptive study about the use of levosimendan in children undergoing surgical correction for congenital heart disease].
Topics: Cardiotonic Agents; Child, Preschool; Comorbidity; Compassionate Use Trials; Coronary Circulation; Down Syndrome; Drug Evaluation; Female; Heart Defects, Congenital; Hemodynamics; Humans; Hydrazones; Hypotension; Infant; Infant, Newborn; Kaplan-Meier Estimate; Male; Myocardial Ischemia; Postoperative Complications; Potassium Channels; Pyridazines; Retrospective Studies; Salvage Therapy; Simendan; Tachycardia | 2012 |
[Levosimendan-long-term inodilation in an infant with myocardial infarction].
Topics: Cardiac Output, Low; Cardiotonic Agents; Coronary Stenosis; Coronary Vessel Anomalies; Echocardiography, Doppler; Electrocardiography, Ambulatory; Humans; Hydrazones; Hypertension, Pulmonary; Infant; Infant, Newborn; Long-Term Care; Male; Myocardial Infarction; Postoperative Complications; Pulmonary Artery; Pulmonary Wedge Pressure; Pyridazines; Simendan; Stroke Volume; Treatment Outcome; Vascular Resistance; Vasodilator Agents | 2004 |
Treatment of acute heart failure in an infant after cardiac surgery using levosimendan.
Topics: Cardiotonic Agents; Female; Heart Arrest; Heart Defects, Congenital; Humans; Hydrazones; Infant; Postoperative Complications; Pyridazines; Simendan | 2004 |
The use of the novel calcium sensitizer levosimendan in critically ill patients.
Topics: Aged; Cardiac Output; Cardiac Output, High; Cardiotonic Agents; Critical Illness; Heart Rate; Humans; Hydrazones; Infusions, Intravenous; Postoperative Complications; Pyridazines; Simendan; Stroke Volume; Vascular Resistance; Vasodilator Agents | 2004 |
Levosimendan: a promising treatment for myocardial stunning?
Topics: Cardiotonic Agents; Facial Neoplasms; Humans; Hydrazones; Male; Middle Aged; Myocardial Ischemia; Myocardial Stunning; Postoperative Complications; Pyridazines; Simendan | 2006 |
Levosimendan may improve survival in patients requiring mechanical assist devices for post-cardiotomy heart failure.
Topics: Aged; Cardiac Output, Low; Cardiac Surgical Procedures; Female; Heart-Assist Devices; Humans; Hydrazones; Intensive Care Units; Male; Middle Aged; Postoperative Complications; Pyridazines; Retrospective Studies; Simendan; Survival Rate; Vasodilator Agents | 2006 |
Levosimendan in severe right ventricular failure following mitral valve replacement.
Topics: Adult; Cardiopulmonary Bypass; Female; Humans; Hydrazones; Hypertension, Pulmonary; Mitral Valve; Mitral Valve Stenosis; Postoperative Complications; Pyridazines; Simendan; Ventricular Dysfunction, Right | 2006 |
Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate.
Topics: Cardiac Output, Low; Cardiotonic Agents; Echocardiography; Follow-Up Studies; Gestational Age; Heart Failure; Humans; Hydrazones; Infant; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Pediatric; Male; Myocardial Stunning; Postoperative Complications; Pyridazines; Simendan; Time Factors; Transposition of Great Vessels; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2007 |
Preoperative levosimendan in heart failure patients undergoing noncardiac surgery.
Topics: Aged; Aged, 80 and over; Cardiotonic Agents; Elective Surgical Procedures; Female; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Postoperative Complications; Preoperative Care; Prospective Studies; Pyridazines; Risk Assessment; Simendan; Ultrasonography | 2008 |